Crossmark

Sodium glucose co-transporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of Atrial Fibrillation in patients with type 2 diabetes mellitus: a meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12872-024-04442-5

Published Online: 2025-01-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liang, Xiaoyan

Dai, Jianghong

Wang, Feifei
License Information

Text and Data Mining valid from 2025-01-28

Version of Record valid from 2025-01-28
More Information

Article History

Received: 2 November 2024

Accepted: 19 December 2024

First Online: 28 January 2025

Declarations

:

: Ethical approval was not applicable for this systematic review and meta-analysis.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below